The lack of validated outcome measures is a key limitation for the evaluation of drug efficacy in the treatment of irritable bowel syndrome (IBS). In clinical trials with tegaserod, the Subject's Global Assessment (SGA) of Relief (a global measure that includes overall wellbeing, abdominal pain/discomfort, and bowel function) was used to identify responders. A total of 1680 patients with IBS with constipation were included in two clinical studies comparing tegaserod with placebo. The SGA of Relief was obtained weekly by a single, self-administered question with five possible answers. Responders for the SGA of Relief reported statistically significant (P<.001) and clinically relevant improvements in multiple IBS-related symptoms compared with nonresponders. Response was also associated with a significant improvement in quality of life. The SGA of Relief is reliable as a new outcome measure for assessing response to therapy in IBS patients and has demonstrated responsiveness and reproducibility.

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0895-4356(03)00027-1DOI Listing

Publication Analysis

Top Keywords

sga relief
12
subject's global
8
global assessment
8
treatment irritable
8
irritable bowel
8
clinical trials
8
relief
4
assessment relief
4
relief appropriate
4
appropriate method
4

Similar Publications

Article Synopsis
  • Post-term pregnancy, reaching or exceeding 42 weeks of gestation, is linked to negative birth outcomes, and while high-income countries often induce labor, low- and middle-income countries lag behind.
  • The study aims to examine the prevalence of post-term births, associated risk factors, and their connections to small-for-gestational-age (SGA) neonates and infant mortality in middle-income settings like Brazil, Mexico, and Palestinian refugees.
  • Analyzing over 45 million live births, the research found that post-term deliveries significantly increased the risk of SGA neonates and infant mortality, suggesting the need for induction strategies to address these issues.
View Article and Find Full Text PDF

Objective: To examine the association between adverse childhood experiences (ACEs) and pregnancy morbidities, including preterm birth (PTB), gestational diabetes (GDM), preeclampsia, and small-for-gestational-age (SGA) among the general population in Japan.

Methods: The data were from the JACSIS study, an online-based nationwide survey conducted from July to August 2021 in Japan (N = 5444). ACEs included physical, sexual, and psychological abuse, neglect, childhood poverty, bully victimization, domestic violence, parental death, and parental divorce.

View Article and Find Full Text PDF

Objective: This study was undertaken to examine the association between different patterns of antiseizure medication (ASM) use during pregnancy and adverse obstetric outcomes (preterm birth, low birth weight [LBW], and small for gestational age [SGA]).

Methods: This retrospective cohort study used the Birth Certificate Application and National Health Insurance data in Taiwan (January 1, 2004 through December 31, 2018). We retrieved weekly ASM among pregnant women with epilepsy who were prepregnancy chronic users and used group-based trajectory modeling to identify distinct patterns of use.

View Article and Find Full Text PDF

Improvement of lidocaine skin permeation by using passive and active enhancer methods.

Int J Pharm

July 2024

Institute of Pharmaceutical Technology and Regulatory Affairs, University of Szeged, Faculty of Pharmacy, 6 Eötvös Str., Szeged H-6720, Hungary. Electronic address:

Lidocaine is generally recognized and preferred for local anaesthesia, but in addition, studies have described additional benefits of lidocaine in cancer therapy, inflammation reduction, and wound healing. These properties contribute to its increasing importance in dermatological applications, and not only in pain relief but also in other potential therapeutic outcomes. Therefore, the purpose of our study was to enhance lidocaine delivery through the skin.

View Article and Find Full Text PDF

Antipsychotic-induced acute laryngeal dystonia: A systematic review of case reports.

Schizophr Res

February 2024

Academic Unit of Psychiatry and Addiction Medicine, The Australian National University School of Medicine and Psychology, Canberra Hospital, Canberra, ACT, Australia; Consortium of Australian-Academic Psychiatrists for Independent Policy and Research Analysis (CAPIPRA), Canberra, ACT, Australia.

Acute laryngeal dystonia (ALD) is a rare but potentially life-threatening complication of both first-generation (FGA) and second-generation (SGA) antipsychotic medication. Delays in diagnosis and treatment have been associated with mortality. We carried out a systematic review of antipsychotic-induced acute laryngeal dystonia using the databases Ovid MEDLINE, PubMed, CINAHL, and EMBASE.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!